Investing
708 Articles
You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 billion…
The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all…
Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…
The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …
The three major US stock indexes opened a bit higher this morning, and after some volatility have managed to get…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…
A US drug advisory panel today denied by a 12-1 vote permission for Amgen Inc. (NASDAQ: AMGN) to market its…
Credit Suisse is making a change in its Global Biotechnology outlook and says the is ‘room to run on generalist…
All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…
Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector. Amgen Inc. (NASDAQ: AMGN)…
Equity markets opened slightly higher this morning but trailed off to negative territory in the late morning. By late afternoon,…
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…
Our top personal finance-related articles today. Your wallet will thank you later.